These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 29486262

  • 1. Dual targeting system by supramolecular complex of folate-conjugated methyl-β-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer.
    Elamin KM, Motoyama K, Higashi T, Yamashita Y, Tokuda A, Arima H.
    Int J Biol Macromol; 2018 Jul 01; 113():386-394. PubMed ID: 29486262
    [Abstract] [Full Text] [Related]

  • 2. Supramolecular Complex of Methyl-β-cyclodextrin with Adamantane-Grafted Hyaluronic Acid as a Novel Antitumor Agent.
    Elamin KM, Yamashita Y, Higashi T, Motoyama K, Arima H.
    Chem Pharm Bull (Tokyo); 2018 Mar 01; 66(3):277-285. PubMed ID: 29269686
    [Abstract] [Full Text] [Related]

  • 3. Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin.
    Kameyama K, Motoyama K, Tanaka N, Yamashita Y, Higashi T, Arima H.
    Int J Nanomedicine; 2017 Mar 01; 12():3433-3446. PubMed ID: 28496320
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of antitumor effects of folate-conjugated methyl-β-cyclodextrin in melanoma.
    Motoyama K, Onodera R, Tanaka N, Kameyama K, Higashi T, Kariya R, Okada S, Arima H.
    Biol Pharm Bull; 2015 Mar 01; 38(3):374-9. PubMed ID: 25757918
    [Abstract] [Full Text] [Related]

  • 5. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.
    Okamatsu A, Motoyama K, Onodera R, Higashi T, Koshigoe T, Shimada Y, Hattori K, Takeuchi T, Arima H.
    Bioconjug Chem; 2013 Apr 17; 24(4):724-33. PubMed ID: 23458386
    [Abstract] [Full Text] [Related]

  • 6. Involvement of autophagy in antitumor activity of folate-appended methyl-β-cyclodextrin.
    Onodera R, Motoyama K, Tanaka N, Ohyama A, Okamatsu A, Higashi T, Kariya R, Okada S, Arima H.
    Sci Rep; 2014 Mar 20; 4():4417. PubMed ID: 24646866
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Potential use of folate-appended methyl-β-cyclodextrin as an anticancer agent.
    Onodera R, Motoyama K, Okamatsu A, Higashi T, Arima H.
    Sci Rep; 2013 Mar 20; 3():1104. PubMed ID: 23346361
    [Abstract] [Full Text] [Related]

  • 10. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
    Saito S, Koya Y, Kajiyama H, Yamashita M, Kikkawa F, Nawa A.
    Cancer Sci; 2020 May 20; 111(5):1794-1804. PubMed ID: 32154964
    [Abstract] [Full Text] [Related]

  • 11. Folate-Appended Hydroxypropyl-β-Cyclodextrin Induces Autophagic Cell Death in Acute Myeloid Leukemia Cells.
    Kubota Y, Hoshiko T, Higashi T, Motoyama K, Okada S, Kimura S.
    Int J Mol Sci; 2023 Nov 24; 24(23):. PubMed ID: 38069042
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo.
    Okamatsu A, Motoyama K, Onodera R, Higashi T, Koshigoe T, Shimada Y, Hattori K, Takeuchi T, Arima H.
    Biomacromolecules; 2013 Dec 09; 14(12):4420-8. PubMed ID: 24175976
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Folic Acid-Appended Hydroxypropyl-β-Cyclodextrin Exhibits Potent Antitumor Activity in Chronic Myeloid Leukemia Cells via Autophagic Cell Death.
    Hoshiko T, Kubota Y, Onodera R, Higashi T, Yokoo M, Motoyama K, Kimura S.
    Cancers (Basel); 2021 Oct 28; 13(21):. PubMed ID: 34771576
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.